nivolumab,rigosertib
onconova therapeutics,SymBio pharmaceuticals,Knight Therapeutics,bms
['lung', 'nivo', 'nivolumab', 'rigoser', 'onconova therapeutics', '$ontx']
#onconova therapeuticstherapeutics announces updated data from investigator-sponsored phase 1/2a trial evaluating #rigosertib in combination with #nivolumab in advanced #krasmutated #nonsmallcelllungcancer at the #esmo22 $ontx 
Follow top-line development in the oncology commercial domain. Gain entry to KOL discussions, including both medical professionals and business leaders.